相互作用
Acalabrutinib + Eptifibatide
重症度: 重大
Acalabrutinib and Eptifibatide: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Acalabrutinib impairs platelet function through BTK inhibition and is associated with bruising and hemorrhage. Adding eptifibatide, a glycoprotein IIb/IIIa inhibitor, increases the likelihood of significant bleeding.
この相互作用をわかりやすく説明すると
Acalabrutinib and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Acalabrutinib belongs to Oncology; Eptifibatide belongs to Cardiovascular.
なぜ起こるのか
Additive impairment of platelet function via BTK inhibition and glycoprotein IIb/IIIa receptor blockade.
対処法
Avoid combining where possible; if eptifibatide is essential, monitor closely for bleeding and hemoglobin. Consider holding acalabrutinib around invasive procedures.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、AcalabrutinibとEptifibatideの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Eptifibatideのその他の相互作用
Acalabrutinibのその他の相互作用
よくある質問
Can I take Acalabrutinib with Eptifibatide?
MediHelp rates the interaction as major. Acalabrutinib and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Acalabrutinib impairs platelet function through BTK inhibition and is associated with bruising and hemorrhage. Adding eptifibatide, a glycoprotein IIb/IIIa inhibitor, increases the likelihood of significant bleeding.
How serious is the interaction between Acalabrutinib and Eptifibatide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible; if eptifibatide is essential, monitor closely for bleeding and hemoglobin. Consider holding acalabrutinib around invasive procedures.
What other medicines interact with Eptifibatide?
MediHelp also lists interactions of Eptifibatide with, for example, Abrocitinib, Acetylsalicylic acid, Antithrombin alfa. The full list is on the Eptifibatide page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
